{"id":3568,"date":"2023-05-16T17:40:16","date_gmt":"2023-05-16T22:40:16","guid":{"rendered":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/?p=3568"},"modified":"2023-05-16T17:40:19","modified_gmt":"2023-05-16T22:40:19","slug":"forgotten-antibiotic-from-decades-ago-could-be-a-superbug-killer","status":"publish","type":"post","link":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/2023\/05\/16\/forgotten-antibiotic-from-decades-ago-could-be-a-superbug-killer\/","title":{"rendered":"Forgotten Antibiotic From Decades Ago Could Be a Superbug Killer"},"content":{"rendered":"<div class=\"panel body-content\"><div class=\"panel__container\">\n<p><a href=\"https:\/\/www.sciencealert.com\/forgotten-antibiotic-from-decades-ago-could-be-a-superbug-killer\">Science Alert<\/a> An antibiotic developed some 80 years ago before being abandoned and forgotten could again offer exciting new solutions, this time to the\u00a0<a href=\"https:\/\/www.sciencealert.com\/nightmare-drug-resistant-superbugs-are-causing-more-deaths-than-previously-estimated\">emerging threat<\/a>\u00a0of drug-resistant superbugs. <\/p>\n\n\n\n<p><a href=\"https:\/\/journals.plos.org\/plosbiology\/article?id=10.1371\/journal.pbio.3002091\">Read the study in PLoS here<\/a><\/p>\n\n\n\n<p><a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC2095086\/\">Half of the bacteria-killing drugs we use today<\/a>&nbsp;are variations of compounds that were found nearly a century ago, during this &#8216;golden age&#8217; of antibiotics. One called streptothricin was&nbsp;<a href=\"https:\/\/journals.sagepub.com\/doi\/abs\/10.3181\/00379727-49-13515\">isolated<\/a>&nbsp;in the 1940s, drawing attention for its potential in treating infections caused by what are known as gram-negative bacteria.<\/p>\n\n\n\n<p>Unlike gram-positive bacteria, these microbes lack a robust cell wall that many antibiotics target.&nbsp;<a href=\"https:\/\/www.sciencealert.com\/arylomycin-analogue-gram-negative-antibiotic-first-in-50-years\">Finding alternatives<\/a>&nbsp;has been one of the big challenges for the pharmaceutical industry. In 2017, the&nbsp;<a href=\"https:\/\/www.sciencealert.com\/what-does-the-world-health-organisation-do\">World Health Organization<\/a>&nbsp;(WHO)&nbsp;<a href=\"https:\/\/www.ncbi.nlm.nih.gov\/pmc\/articles\/PMC7144564\/\">released<\/a>&nbsp;a list of the most dangerous, drug-resistant pathogens out there. Most were gram-negative bacteria.<\/p>\n\n\n\n<p>But despite its potential for killing bacteria, streptothricin didn&#8217;t make the cut. It was deemed too toxic to the health of human kidneys in an initial study and was subsequently buried in the scientific literature.<\/p>\n\n\n\n<p>Pathologist James Kirby from Harvard University and his colleagues are now digging it back up, exploring its potential under a new name \u2013\u00a0<a href=\"https:\/\/en.wikipedia.org\/wiki\/Nourseothricin\">nourseothricin<\/a>. <\/p>\n\n\n\n<p>&#8220;Now with the emergence of multi-drug resistant pathogens, for which there are few if any active antibiotics available for treatment, it is time to revisit and explore the potential of what we have previously overlooked,&#8221; Kirby told ScienceAlert.<\/p>\n\n\n\n<p>Nourseothricin is a natural product made by soil bacteria that are gram-positive. It is actually a mixture of antibiotics, given individual names such as streptothricin F (S-F) and streptothricin D (S-D).<\/p>\n\n\n\n<p>While nourseothricin and S-D show toxic effects on kidney cells in the lab, Kirby and his colleagues have now established that isn&#8217;t the case for S-F. This compound is still highly effective at killing drug-resistant gram-negative bacteria but at concentrations that are not toxic.<\/p>\n\n\n\n<p>In mouse models, S-F actually managed to kill off a strain of bacteria that has proved resistant to numerous existing drugs, all with minimal to no toxicity. <\/p>\n\n\n\n<p>&#8220;Soil-dwelling bacteria in their quest for maintaining their turf have figured out through eons of evolution how to make antibiotics that can penetrate the armor of gram-negative bacteria. Streptothricins are one of the results of this ongoing arms race,&#8221; said Kirby.<\/p>\n\n\n\n<p>&#8220;These compounds offer a distinctive solution for penetrating the defense mechanisms of gram-negative pathogens.&#8221;<\/p>\n\n\n\n<p>The precise details behind streptothricin&#8217;s attack are not yet clear, but it seems as though the antibiotic binds to gram-negative bacteria and messes with its protein-making machinery in a different way to other medicines.<\/p>\n\n\n\n<p>If researchers can figure out how, it could help them develop a whole new class of medicine for bacteria that have so far proved highly resistant.<\/p>\n\n\n\n<p>Kirby and his colleagues have already started exploring how to enhance natural streptothricins, like S-F, to work even better as superbug killers.<\/p>\n\n\n\n<p>He says they &#8220;look forward to a resurgence of interest in this historically significant, yet long-forgotten class of antibiotics.&#8221;<\/p>\n<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>Science Alert An antibiotic developed some 80 years ago before being abandoned and forgotten could again offer exciting new solutions, this time to the\u00a0emerging threat\u00a0of drug-resistant superbugs. Read the study in PLoS here Half of the bacteria-killing drugs we use today&nbsp;are variations of compounds that were found nearly a century ago, during this &#8216;golden age&#8217; [&hellip;]<\/p>\n","protected":false},"author":11,"featured_media":3569,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_jetpack_memberships_contains_paid_content":false,"footnotes":"","jetpack_publicize_message":"","jetpack_publicize_feature_enabled":false,"jetpack_social_post_already_shared":false,"jetpack_social_options":{"image_generator_settings":{"template":"highway","default_image_id":0,"font":"","enabled":false},"version":2}},"categories":[21],"tags":[],"class_list":["post-3568","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-featured"],"jetpack_publicize_connections":[],"jetpack_featured_media_url":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-content\/uploads\/2023\/05\/Screenshot-2023-05-16-at-18.18.59.png","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/posts\/3568","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/users\/11"}],"replies":[{"embeddable":true,"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/comments?post=3568"}],"version-history":[{"count":1,"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/posts\/3568\/revisions"}],"predecessor-version":[{"id":3570,"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/posts\/3568\/revisions\/3570"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/media\/3569"}],"wp:attachment":[{"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/media?parent=3568"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/categories?post=3568"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.unmc.edu\/healthsecurity\/transmission\/wp-json\/wp\/v2\/tags?post=3568"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}